Prevalence and phylogenetic characterisation of TT-virus in the blood donor population of Auckland, New Zealand

• Published in: Journal of medical virology Vol. 62; no. 1; pp. 109 - 114
• Main Authors: Werno, A.M., Wang, Z., Schroeder, B.A., Woodfield, G., Croxson, M.C.
• Format: Journal Article
• Language: English
• Published: New York John Wiley & Sons, Inc 01-09-2000; Wiley-Liss
• Subjects: Biological and medical sciences; Blood Donors; DNA Virus Infections - epidemiology; DNA Virus Infections - virology; DNA Viruses - isolation & purification; DNA, Viral - analysis; DNA, Viral - blood; Epidemiology; Fundamental and applied biological sciences. Psychology; Genotype; genotypes; Human viral diseases; Humans; Infectious diseases; Medical sciences; Microbiology; Molecular Sequence Data; New Zealand - epidemiology; New Zealand, Auckland; phylogenetic analysis; Phylogeny; Polymerase Chain Reaction; Prevalence; Sequence Alignment; Sequence Analysis, DNA; TT virus; Viral diseases; Viral hepatitis; Virology; New Zealand; Oceania; Virus; Human; Prevalence; Nucleotide sequence; TT virus; Genotype; Phylogeny; Epidemiology; Blood donor
• ISSN: 0146-6615; 1096-9071
• DOI: 10.1002/1096-9071(200009)62:1<109::AID-JMV17>3.0.CO;2-H

TT‐virus (TTV, patient initials: T.T.), a novel DNA virus, was first isolated in Japan in 1997 from serum of a patient with post‐transfusion hepatitis of unknown aetiology. To date, the contribution of TTV to liver disease remains doubtful. The potential for transmission via blood and blood products makes it essential to establish the prevalence of TTV viraemia in the blood donor population. 413 blood donor serum samples were chosen randomly, the DNA was extracted and TTV‐specific DNA amplified by nested polymerase chain reaction (PCR). TTV infection was present in 13 out of 413 (3.15%) blood donors in the Auckland region of New Zealand using a set of primers targeting open reading frame (ORF) 1. These 13 amplification products (264 bp) were sequenced and TTV genotypes determined. Alignment with published TTV sequences showed that seven (53.8%) of the thirteen positive serum samples belonged to genotype 1, five (38.5%) belonged to genotype 2 and one (7.7%) could not be classified as either genotype 1 or 2. One hundred twenty‐seven blood donor serum samples were retested with a second set of primers targeting the 5′ region of the TTV genome in a single round PCR. Forty‐three samples were positive for TTV DNA with these primers resulting in a prevalence of 37%. The data demonstrate that TTV is present among New Zealand blood donors and support the need for further investigation into the natural history of TTV infection. J. Med. Virol. 62:109–114, 2000. © 2000 Wiley‐Liss, Inc.